Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcipotriol AKVANO in Psoriasis Vulgaris
NCT05488990Phase 2Completed
- Sponsor
- Lipidor
- Start
- Mar 2013
- Primary completion
- Jun 2013
- Countries
- 1
01
Overview
A Phase 2 trial of AKP01 in Psoriasis vulgaris (PV), sponsored by Lipidor. Started Mar 2013; status: completed.
02
Drugs
AKP01
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT05488990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05488990.